tradingkey.logo

EMS Chemie rises on core profit margins beat, confirms FY guidance

ReutersJul 11, 2025 7:32 AM

Shares in EMS Chemie EMSN.S rise 2.2% after the Swiss chemical company posted its core profit margins above expectations, despite lower H1 sales

EMS posts H1 EBITDA at 323 million Swiss francs ($405.58 million), with a margin of 31.7%, compared to 319 million and 29.4% last year

Its H1 EBIT amounts to 296 million Swiss francs with a margin of 29% vs 291 million and 26.8% in 2024

"H1 sales lower than expected. This was compensated by clearly improved margins, which are the highlight of the set of figures," Vontobel says, citing margins came in ahead of market expectations

"We see a certain risk in potential U.S. tariffs on Swiss products, but in general, we see favorable long-term growth trends in EMS' key markets," it adds

The company posted H1 sales at 1.02 billion Swiss francs vs 1.09 billion a year earlier, and confirmed its FY guidance

($1 = 0.7964 Swiss francs)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI